FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001716963> ?p ?o ?g. }

• W2001716963 endingPage "77" @default.
• W2001716963 startingPage "72" @default.
• W2001716963 abstract "Background: Vulvovaginal candidiasis (VVC) is one of the major urogenital infections for which women seek medical treatment or use self-prescribed antifungals. The objective of this study was to investigate whether probiotic lactobacilli can be used as an adjunctive treatment in the management of VVC in Nigerian women. Patients and methods: Fifty-nine premenopausal women attending health clinics were diagnosed with vaginal yeast infection by both clinical assessment and standard laboratory culture techniques. After informed consent, they were randomized blindly to receive a conventional single oral dose of fluconazole (150 mg) and a daily probiotic capsule containing Lactobacillus rhamnosus GR-1 and Lactobacillusreuteri RC-14 or placebo for 3 months (90 days). Results: At day 7, 47 of the 59 patients attended for follow-up. Seven of the 33 on probiotics (23%) and 2 of 14 on placebo (14%) had evidence of yeast infection by culture on day 7 (p>0.1), indicating a cure rate of approximately 80% with single dose fluconazole. However, of the 26 subjects who reported at day 90, 79% who received probiotics were free of yeast infection compared with 43% on placebo (p =0.1490). PCR confirmed this finding, as 75% in the probiotics group were negative for heat shock protein specific for Candida albicans at day 90. A PCR primer set specific for L. rhamnosus GR-1 and L. reuteri RC-14 revealed the presence of the Lactobacillus strains on day 90 in 25% of the subjects who took probiotics. All the patients in the placebo group (100%) had two or three recurrences during the 90 day follow-up, while 53% of the probiotics group had one to two recurrences (p =0.05). Conclusion: The study shows that adjunctive treatment of VVC with probiotic L. rhamnosus GR-1 and L. reuteri RC-14 did not impact the cure rate at day 7, but did lead to fewer vulvovaginitis recurrences. Problems with patients returning for follow-up appointments suggest the need for a more active education programme in Nigeria on clinical trials per se and probiotics in particular.Clinical Trial Registration Number: NCT00479947." @default.
• W2001716963 created "2016-06-24" @default.
• W2001716963 creator A5025410193 @default.
• W2001716963 creator A5032125717 @default.
• W2001716963 creator A5037927576 @default.
• W2001716963 creator A5040157560 @default.
• W2001716963 creator A5043064717 @default.
• W2001716963 creator A5064770498 @default.
• W2001716963 creator A5086921785 @default.
• W2001716963 date "2009-01-01" @default.
• W2001716963 modified "2023-09-27" @default.
• W2001716963 title "Oral use of probiotics as an adjunctive therapy to fluconazole in the treatment of yeast vaginitis: A study of Nigerian women in an outdoor clinic" @default.
• W2001716963 cites W1521271354 @default.
• W2001716963 cites W1546580461 @default.
• W2001716963 cites W1930313341 @default.
• W2001716963 cites W1982622206 @default.
• W2001716963 cites W2062478417 @default.
• W2001716963 cites W2067480270 @default.
• W2001716963 cites W2103147394 @default.
• W2001716963 cites W2106311471 @default.
• W2001716963 cites W2119994555 @default.
• W2001716963 cites W2130187365 @default.
• W2001716963 cites W2143836943 @default.
• W2001716963 cites W2149188810 @default.
• W2001716963 cites W88550186 @default.
• W2001716963 doi "https://doi.org/10.1080/08910600902907475" @default.
• W2001716963 hasPublicationYear "2009" @default.
• W2001716963 type Work @default.
• W2001716963 sameAs 2001716963 @default.
• W2001716963 citedByCount "11" @default.
• W2001716963 countsByYear W20017169632016 @default.
• W2001716963 countsByYear W20017169632017 @default.
• W2001716963 countsByYear W20017169632019 @default.
• W2001716963 countsByYear W20017169632020 @default.
• W2001716963 countsByYear W20017169632021 @default.
• W2001716963 countsByYear W20017169632022 @default.
• W2001716963 crossrefType "journal-article" @default.
• W2001716963 hasAuthorship W2001716963A5025410193 @default.
• W2001716963 hasAuthorship W2001716963A5032125717 @default.
• W2001716963 hasAuthorship W2001716963A5037927576 @default.
• W2001716963 hasAuthorship W2001716963A5040157560 @default.
• W2001716963 hasAuthorship W2001716963A5043064717 @default.
• W2001716963 hasAuthorship W2001716963A5064770498 @default.
• W2001716963 hasAuthorship W2001716963A5086921785 @default.
• W2001716963 hasBestOaLocation W20017169631 @default.
• W2001716963 hasConcept C126322002 @default.
• W2001716963 hasConcept C142724271 @default.
• W2001716963 hasConcept C16005928 @default.
• W2001716963 hasConcept C204787440 @default.
• W2001716963 hasConcept C27081682 @default.
• W2001716963 hasConcept C2776651480 @default.
• W2001716963 hasConcept C2777617518 @default.
• W2001716963 hasConcept C2778489779 @default.
• W2001716963 hasConcept C2779548794 @default.
• W2001716963 hasConcept C2780206646 @default.
• W2001716963 hasConcept C2780255968 @default.
• W2001716963 hasConcept C2780651595 @default.
• W2001716963 hasConcept C2780917455 @default.
• W2001716963 hasConcept C29456083 @default.
• W2001716963 hasConcept C523546767 @default.
• W2001716963 hasConcept C54355233 @default.
• W2001716963 hasConcept C71924100 @default.
• W2001716963 hasConcept C86803240 @default.
• W2001716963 hasConcept C89423630 @default.
• W2001716963 hasConceptScore W2001716963C126322002 @default.
• W2001716963 hasConceptScore W2001716963C142724271 @default.
• W2001716963 hasConceptScore W2001716963C16005928 @default.
• W2001716963 hasConceptScore W2001716963C204787440 @default.
• W2001716963 hasConceptScore W2001716963C27081682 @default.
• W2001716963 hasConceptScore W2001716963C2776651480 @default.
• W2001716963 hasConceptScore W2001716963C2777617518 @default.
• W2001716963 hasConceptScore W2001716963C2778489779 @default.
• W2001716963 hasConceptScore W2001716963C2779548794 @default.
• W2001716963 hasConceptScore W2001716963C2780206646 @default.
• W2001716963 hasConceptScore W2001716963C2780255968 @default.
• W2001716963 hasConceptScore W2001716963C2780651595 @default.
• W2001716963 hasConceptScore W2001716963C2780917455 @default.
• W2001716963 hasConceptScore W2001716963C29456083 @default.
• W2001716963 hasConceptScore W2001716963C523546767 @default.
• W2001716963 hasConceptScore W2001716963C54355233 @default.
• W2001716963 hasConceptScore W2001716963C71924100 @default.
• W2001716963 hasConceptScore W2001716963C86803240 @default.
• W2001716963 hasConceptScore W2001716963C89423630 @default.
• W2001716963 hasIssue "2" @default.
• W2001716963 hasLocation W20017169631 @default.
• W2001716963 hasOpenAccess W2001716963 @default.
• W2001716963 hasPrimaryLocation W20017169631 @default.
• W2001716963 hasRelatedWork W2075994397 @default.
• W2001716963 hasRelatedWork W2097453265 @default.
• W2001716963 hasRelatedWork W2341432746 @default.
• W2001716963 hasRelatedWork W2415100924 @default.
• W2001716963 hasRelatedWork W3014810055 @default.
• W2001716963 hasRelatedWork W3152660408 @default.
• W2001716963 hasRelatedWork W3159027947 @default.
• W2001716963 hasRelatedWork W4251393149 @default.
• W2001716963 hasRelatedWork W4286255305 @default.
• W2001716963 hasRelatedWork W3156555198 @default.
• W2001716963 hasVolume "21" @default.

• next